Board of Directors
David C. Pollack
Co-Founder, CEO, Chairman of the Board
​David C. Pollack, Co-Founder, Chairman of the Board and CEO
Mr. Pollack is the son of Dr. William Pollack, the developer of RhoGAM and Hepatitis B Immune Globulin. David worked closely with his father on this project for more than 10 years and also provided millions in support for his father’s research. He helped co-develop the Company’s fractionation manufacturing process and much of the Company’s platform of technology. He spent years with his father focused on the key elements of immune control, product specification and production. With a significant base of immunological knowledge, Mr. Pollack led the development of a precise immunoglobulin fractionation process and produced the Streptococcus Pneumoniae human polyvalent antibody. He helped design and build the class 5 clean rooms and founded the Company. He has reviewed with the Quotient team thousands of technical papers and every element of the Company’s core technology, production and IP.
David is a financier and corporate executive with experience spanning a wide range of business activities, including corporate management, new technology commercialization, underwriting, and capital formation. He has a strong background in corporate, secured-debt, project-finance and the capital markets. David has raised over a billion dollars in capital across multiple business sectors including large industrial operations. He has experience in the funding and commercialization of technology and has been responsible for the issuance of over 350 patents worldwide.
Dr. Randal Vecchione, M.D.
Co-Founder, Director of Clinical Affairs, Board Member
Dr. Randal Vecchione is a co-founder of Quotient Pharmaceuticals Manufacturing and serves as the Director of Clinical Affairs and voting Board Member. Dr. Vecchione is a prominent reconstructive surgeon with over 44 years experience, who also currently serves as Chief of Reconstructive Plastic Surgery at Scripps Mercy Hospital and is a key member of the surgical teams at Sharp Memorial, Mercy Rady Children's Hospital San Diego, and Scripps Memorial.
Dr. Vecchione has years of frontline experience in treating rampant bacterial infections, and has seen first-hand the acute problems, suffering, and death associated with antibiotic-resistant bacteria, and treating the immune suppressed. Dr. Vecchione worked closely with Dr. Pollack for many years and together treated patients using Intravenous Gama Globulin (IVIG) who were overrun with flesh-eating or other bacterial infections resistant to antibiotic treatments.
James R. Phillion
Board Director
​​Mr. Philion has had an impressive career in the automotive industry. Among his many accomplishments, he served as Chief Operating Officer of Thrifty Car Rental Worldwide System and Executive Vice President of Pentastar Transportation Group, Inc., a division of Chrysler Corporation overseeing Thrifty Rent-a-Car and Dollar Rent-a-Car. Mr. Philion led the team responsible for restructuring the growth of Thrifty and forming its alliance with Chrysler Corporation. Under his direction, Thrifty substantially increased market share, became a publically-traded company, and was ultimately sold to Chrysler.
​Mr. Philion’s wealth of knowledge will undoubtedly help build the foundation for the Company’s sales and marketing strategies. In addition, he will help Quotient identify, attract, and select key talent for the Company’s growth.
Joaquin Serra
Board Director - Marketing Advisor
Mr. Serra is an internationally recognized expert in the sales and marketing of health and beauty products many requiring regulatory approval at Natura Bisse. Mr. Serra has contributed to the development of a worldwide high-end direct sales business in the fiercely competitive beauty products industry. He is an expert in creating impactful marketing programs and executing the development of international business.